OneSource pharma launches new brand identity at CPHI, Milan
OneSource Pharma targets biologics and drug-device markets with end-to-end solutions and global expansion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GLP-1
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist…
Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…